152 related articles for article (PubMed ID: 10233901)
1. The T-cell activation markers CD30 and OX40/CD134 are expressed in nonoverlapping subsets of peripheral T-cell lymphoma.
Jones D; Fletcher CD; Pulford K; Shahsafaei A; Dorfman DM
Blood; 1999 May; 93(10):3487-93. PubMed ID: 10233901
[TBL] [Abstract][Full Text] [Related]
2. Expression of T-cell activation marker CD134 (OX40) in lymphomatoid papulosis.
Gniadecki R; Rossen K
Br J Dermatol; 2003 May; 148(5):885-91. PubMed ID: 12786817
[TBL] [Abstract][Full Text] [Related]
3. Expression pattern of T-cell-associated chemokine receptors and their chemokines correlates with specific subtypes of T-cell non-Hodgkin lymphoma.
Jones D; O'Hara C; Kraus MD; Perez-Atayde AR; Shahsafaei A; Wu L; Dorfman DM
Blood; 2000 Jul; 96(2):685-90. PubMed ID: 10887135
[TBL] [Abstract][Full Text] [Related]
4. CXCR4/CD184 immunoreactivity in T-cell non-Hodgkin lymphomas with an overall Th1- Th2+ immunophenotype.
Weng AP; Shahsafaei A; Dorfman DM
Am J Clin Pathol; 2003 Mar; 119(3):424-30. PubMed ID: 12645345
[TBL] [Abstract][Full Text] [Related]
5. Phenotypic characterization of subsets of T cell lymphoma: towards a functional classification of T cell lymphoma.
Jones D; Dorfman DM
Leuk Lymphoma; 2001 Feb; 40(5-6):449-59. PubMed ID: 11426518
[TBL] [Abstract][Full Text] [Related]
6. CD30 distribution. Immunohistochemical study on formaldehyde-fixed, paraffin-embedded Hodgkin's and non-Hodgkin's lymphomas.
Miettinen M
Arch Pathol Lab Med; 1992 Nov; 116(11):1197-201. PubMed ID: 1332642
[TBL] [Abstract][Full Text] [Related]
7. Th1, Th2, and activated T-cell marker and clinical prognosis in peripheral T-cell lymphoma, unspecified: comparison with AILD, ALCL, lymphoblastic lymphoma, and ATLL.
Tsuchiya T; Ohshima K; Karube K; Yamaguchi T; Suefuji H; Hamasaki M; Kawasaki C; Suzumiya J; Tomonaga M; Kikuchi M
Blood; 2004 Jan; 103(1):236-41. PubMed ID: 12958063
[TBL] [Abstract][Full Text] [Related]
8. Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.
Kotani A; Ishikawa T; Matsumura Y; Ichinohe T; Ohno H; Hori T; Uchiyama T
Blood; 2001 Nov; 98(10):3162-4. PubMed ID: 11698307
[TBL] [Abstract][Full Text] [Related]
9. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
Nguyen PL; Harris NL; Ritz J; Robertson MJ
Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
[TBL] [Abstract][Full Text] [Related]
10. The activation profile of tumour-associated reactive T-cells differs in the nodular and diffuse patterns of lymphocyte predominant Hodgkin's disease.
Lin P; Medeiros LJ; Wilder RB; Abruzzo LV; Manning JT; Jones D
Histopathology; 2004 Jun; 44(6):561-9. PubMed ID: 15186271
[TBL] [Abstract][Full Text] [Related]
11. CD30 expression identifies the predominant proliferating T lymphocyte population in human alloimmune responses.
Chan KW; Hopke CD; Krams SM; Martinez OM
J Immunol; 2002 Aug; 169(4):1784-91. PubMed ID: 12165500
[TBL] [Abstract][Full Text] [Related]
12. Anaplastic large-cell lymphomas of B-cell phenotype are anaplastic lymphoma kinase (ALK) negative and belong to the spectrum of diffuse large B-cell lymphomas.
Haralambieva E; Pulford KA; Lamant L; Pileri S; Roncador G; Gatter KC; Delsol G; Mason DY
Br J Haematol; 2000 Jun; 109(3):584-91. PubMed ID: 10886208
[TBL] [Abstract][Full Text] [Related]
13. CD30 ligand, a member of the TNF ligand superfamily, with growth and activation control CD30+ lymphoid and lymphoma cells.
Gruss H-J ; Herrmann F
Leuk Lymphoma; 1996 Feb; 20(5-6):397-409. PubMed ID: 8833395
[TBL] [Abstract][Full Text] [Related]
14. CD25 expression distinguishes functionally distinct alloreactive CD4 CD134 (OX40) T-cell subsets in acute graft-versus-host disease.
Streeter PR; Zhang X; Tittle TV; Schön CN; Weinberg AD; Maziarz RT
Biol Blood Marrow Transplant; 2004 May; 10(5):298-309. PubMed ID: 15111929
[TBL] [Abstract][Full Text] [Related]
15. Expression of CD30 and Ox40 on T lymphocyte subsets is controlled by distinct regulatory mechanisms.
Toennies HM; Green JM; Arch RH
J Leukoc Biol; 2004 Feb; 75(2):350-7. PubMed ID: 14634058
[TBL] [Abstract][Full Text] [Related]
16. Peripheral T-cell lymphomas of follicular helper T-cell type frequently display an aberrant CD3(-/dim)CD4(+) population by flow cytometry: an important clue to the diagnosis of a Hodgkin lymphoma mimic.
Alikhan M; Song JY; Sohani AR; Moroch J; Plonquet A; Duffield AS; Borowitz MJ; Jiang L; Bueso-Ramos C; Inamdar K; Menon MP; Gurbuxani S; Chan E; Smith SM; Nicolae A; Jaffe ES; Gaulard P; Venkataraman G
Mod Pathol; 2016 Oct; 29(10):1173-82. PubMed ID: 27312067
[TBL] [Abstract][Full Text] [Related]
17. Sequential development of Hodgkin's disease and CD30+ diffuse large B-cell lymphoma in a patient with MALT-type lymphoma: evidence of different clonal origin of single microdissected Reed-Sternberg cells.
Parrens M; Vergier B; Fitoussi O; Lahet C; Belleannee G; Marit G; Dubus P; de Mascarel A; Delfau-Larue MH; Merlio JP
Am J Surg Pathol; 2002 Dec; 26(12):1634-42. PubMed ID: 12459631
[TBL] [Abstract][Full Text] [Related]
18. Strong expression of CD134 (OX40), a member of the TNF receptor family, in a T helper 2-type cytokine environment.
Roos A; Schilder-Tol EJ; Weening JJ; Aten J
J Leukoc Biol; 1998 Oct; 64(4):503-10. PubMed ID: 9766631
[TBL] [Abstract][Full Text] [Related]
19. Expression of CD134 (0X-40) on T cells during the first 100 days following allogeneic bone marrow transplantation as a marker for lymphocyte activation and therapy-resistant graft-versus-host disease.
Lamb LS; Abhyankar SA; Hazlett L; O'Neal W; Folk RS; Vogt S; Parrish RS; Bridges K; Henslee-Downey PJ; Gee AP
Cytometry; 1999 Oct; 38(5):238-43. PubMed ID: 10516610
[TBL] [Abstract][Full Text] [Related]
20. Expression of T cell activation antigen CD134 (OX40) has no predictive value for the occurrence or response to therapy of acute graft-versus-host disease in partial T cell-depleted bone marrow transplantation.
Gadisseur AP; Gratama JW; Lamers C; van Esser JW; Bolhuis RL; Cornelissen JJ
Bone Marrow Transplant; 1999 May; 23(10):1013-7. PubMed ID: 10373067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]